Literature DB >> 26592192

Chronic kidney disease: suPAR in CKD.

Susan J Allison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26592192     DOI： 10.1038/nrneph.2015.195

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Soluble Urokinase Receptor and Chronic Kidney Disease.

Authors:  Salim S Hayek; Sanja Sever; Yi-An Ko; Howard Trachtman; Mosaab Awad; Shikha Wadhwani; Mehmet M Altintas; Changli Wei; Anna L Hotton; Audrey L French; Laurence S Sperling; Stamatios Lerakis; Arshed A Quyyumi; Jochen Reiser
Journal:  N Engl J Med       Date:  2015-11-05       Impact factor: 91.245
  1 in total
  3 in total

1.  Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.

Authors:  Christiane Drechsler; Salim S Hayek; Changli Wei; Sanja Sever; Bernd Genser; Vera Krane; Andreas Meinitzer; Winfried März; Christoph Wanner; Jochen Reiser
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-11       Impact factor: 8.237

2.  Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography.

Authors:  Claudia Sommerer; Martin Zeier; Christian Morath; Jochen Reiser; Hubert Scharnagl; Tatjana Stojakovic; Graciela E Delgado; Winfried März; Marcus E Kleber
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

Review 3.  Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease.

Authors:  Yinghui Wang; Lu Gao
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.